KKR agrees to sell 10% Nordic Bioscience stake to founder Claus Christiansen - KKR News | RalliesKKR agrees to sell 10% Nordic Bioscience stake to founder Claus Christiansen
K
KKR• KKR to sell minority stake to founder
- KKR agreed to sell its 10% minority stake in Nordic Bioscience to founder and majority shareholder Claus Christiansen.
- Investment dates back to 2021 via KKR’s Health Care Strategic Growth strategy.
- KKR partner Kugan Sathiyanandarajah will stay on Nordic Bioscience’s board until the next ordinary general meeting.
- Chair Håkan Björklund will step down from the board; Christiansen will take over as chair.
•
